IL33336A0 - 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them - Google Patents
1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing themInfo
- Publication number
- IL33336A0 IL33336A0 IL33336A IL3333669A IL33336A0 IL 33336 A0 IL33336 A0 IL 33336A0 IL 33336 A IL33336 A IL 33336A IL 3333669 A IL3333669 A IL 3333669A IL 33336 A0 IL33336 A0 IL 33336A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrazin
- imidazo
- ones
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77747868A | 1968-11-20 | 1968-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL33336A0 true IL33336A0 (en) | 1970-01-29 |
Family
ID=25110370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL33336A IL33336A0 (en) | 1968-11-20 | 1969-11-10 | 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3567725A (de) |
| AT (1) | AT290528B (de) |
| BE (1) | BE741910A (de) |
| BR (1) | BR6914329D0 (de) |
| DE (2) | DE1965989A1 (de) |
| FR (1) | FR2035817B1 (de) |
| GB (1) | GB1246006A (de) |
| IL (1) | IL33336A0 (de) |
| NL (1) | NL6915957A (de) |
| ZA (1) | ZA698081B (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8810933D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Heterocyclic compounds |
| GB8810934D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Amides |
| US5705585A (en) * | 1993-06-30 | 1998-01-06 | Arqule, Inc. | Aminimide-containing molecules and materials as molecular recognition agents |
| AU704878B2 (en) * | 1994-01-05 | 1999-05-06 | Arqule, Inc. | Method of making polymers having specific properties |
| US7034110B2 (en) * | 1994-01-05 | 2006-04-25 | Arqule, Inc. | Method of identifying chemical compounds having selected properties for a particular application |
| US5734082A (en) * | 1994-10-20 | 1998-03-31 | Arqule Inc. | Hydroxyethyl aminimides |
| US5712171A (en) * | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
| WO1996031263A1 (en) * | 1995-04-06 | 1996-10-10 | Arqule, Inc. | Method for rapid purification, analysis and characterization of collections of chemical compounds |
| US5962412A (en) * | 1996-06-10 | 1999-10-05 | Arqule, Inc. | Method of making polymers having specific properties |
| EP2078016B1 (de) | 2006-10-19 | 2012-02-01 | Signal Pharmaceuticals LLC | Heteroarylverbindungen, zusammensetzungen daraus und behandlungsverfahren damit |
| US8110578B2 (en) | 2008-10-27 | 2012-02-07 | Signal Pharmaceuticals, Llc | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway |
| ES2751705T3 (es) | 2009-10-26 | 2020-04-01 | Signal Pharm Llc | Métodos de síntesis y purificación de compuestos heteroarilo |
| MX384385B (es) | 2011-10-19 | 2025-03-14 | Signal Pharm Llc | Tratamiento del cancer con inhibidores de tor cinasa |
| JP6076370B2 (ja) | 2011-12-02 | 2017-02-08 | シグナル ファーマシューティカルズ，エルエルシー | ７−（６−（２−ヒドロキシプロパン−２−イル）ピリジン−３−イル）−１−（（トランス）−４−メトキシシクロヘキシル）−３，４−ジヒドロピラジノ［２，３−ｂ］ピラジン−２（１Ｈ）−オンの薬剤組成物、その固体形態、およびその使用方法 |
| US9375443B2 (en) | 2012-02-24 | 2016-06-28 | Signal Pharmaceuticals, Llc | Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib |
| AU2013203714B2 (en) | 2012-10-18 | 2015-12-03 | Signal Pharmaceuticals, Llc | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity |
| AR094494A1 (es) | 2013-01-16 | 2015-08-05 | Signal Pharm Llc | Pirrolopirimidinas sustituidas, sus composiciones, y sus métodos de tratamiento |
| US9782427B2 (en) | 2013-04-17 | 2017-10-10 | Signal Pharmaceuticals, Llc | Methods for treating cancer using TOR kinase inhibitor combination therapy |
| SG11201508223YA (en) | 2013-04-17 | 2015-11-27 | Signal Pharm Llc | Treatment of cancer with dihydropyrazino-pyrazines |
| EP3549940A1 (de) | 2013-04-17 | 2019-10-09 | Signal Pharmaceuticals, LLC | Pharmazeutische formulierungen von 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)-pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-on |
| EP2986319A1 (de) | 2013-04-17 | 2016-02-24 | Signal Pharmaceuticals, LLC | Kombinationstherapie mit einem torkinaseinhibitor und n-(3-(5-fluor-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamid zur behandlung von krebs |
| JP6382949B2 (ja) | 2013-04-17 | 2018-08-29 | シグナル ファーマシューティカルズ，エルエルシー | 癌を治療するためのｔｏｒキナーゼ阻害剤及び５−置換キナゾリノン化合物を含む組合せ療法 |
| HK1221150A1 (zh) | 2013-04-17 | 2017-05-26 | 西格诺药品有限公司 | 用二氢吡嗪并-吡嗪类对癌症的治疗 |
| WO2014172431A1 (en) | 2013-04-17 | 2014-10-23 | Signal Pharmaceuticals, Llc | Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer |
| GB201309508D0 (en) * | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
| US9604939B2 (en) | 2013-05-29 | 2017-03-28 | Signal Pharmaceuticals, Llc | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use |
| US9718824B2 (en) | 2014-04-16 | 2017-08-01 | Signal Pharmaceuticals, Llc | Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof |
| ES2823756T3 (es) | 2014-04-16 | 2021-05-10 | Signal Pharm Llc | Métodos para tratar el cáncer usando terapia de combinación de inhibidores de quinasa TOR |
| NZ714742A (en) | 2014-04-16 | 2017-04-28 | Signal Pharm Llc | Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use |
| JP2017511367A (ja) | 2014-04-16 | 2017-04-20 | シグナル ファーマシューティカルズ，エルエルシー | １−エチル−７−（２−メチル−６−（１Ｈ−１，２，４−トリアゾール−３−イル）ピリジン−３−イル）−３，４−ジヒドロピラジノ［２，３−ｂ］ピラジン−２（１Ｈ）−オン及び共形成物を含む固体形態、その組成物及び使用方法 |
| CN106715427A (zh) | 2014-07-14 | 2017-05-24 | 西格诺药品有限公司 | 利用取代的吡咯并嘧啶化合物、其组合物治疗癌症的方法 |
| NZ629796A (en) | 2014-07-14 | 2015-12-24 | Signal Pharm Llc | Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use |
| MY198676A (en) | 2017-06-22 | 2023-09-15 | Celgene Corp | Treatment of hepatocellular carcinoma characterized by hepatitis b virus infection |
-
1968
- 1968-11-20 US US777478A patent/US3567725A/en not_active Expired - Lifetime
-
1969
- 1969-10-22 NL NL6915957A patent/NL6915957A/xx unknown
- 1969-11-10 IL IL33336A patent/IL33336A0/xx unknown
- 1969-11-17 DE DE19691965989 patent/DE1965989A1/de active Pending
- 1969-11-17 DE DE19691957711 patent/DE1957711A1/de active Pending
- 1969-11-17 GB GB56181/69A patent/GB1246006A/en not_active Expired
- 1969-11-19 AT AT1082569A patent/AT290528B/de not_active IP Right Cessation
- 1969-11-19 BR BR214329/69A patent/BR6914329D0/pt unknown
- 1969-11-19 BE BE741910D patent/BE741910A/xx unknown
- 1969-11-19 ZA ZA698081*A patent/ZA698081B/xx unknown
- 1969-11-20 FR FR696939941A patent/FR2035817B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2035817B1 (de) | 1973-01-12 |
| GB1246006A (en) | 1971-09-15 |
| FR2035817A1 (de) | 1970-12-24 |
| AT290528B (de) | 1971-06-11 |
| DE1965989A1 (de) | 1971-02-18 |
| US3567725A (en) | 1971-03-02 |
| DE1957711A1 (de) | 1970-06-18 |
| NL6915957A (de) | 1970-05-22 |
| BE741910A (de) | 1970-05-19 |
| ZA698081B (en) | 1971-07-28 |
| BR6914329D0 (pt) | 1973-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL33336A0 (en) | 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing them | |
| YU215269A (en) | Process for preparing novel 11-substituted 5,11-dihydro-6h-pyrido (2,3-b) (184)benzodiazepin-6-ones | |
| IL30463A0 (en) | 1h-imidazo(4,5-beta)pyrazine-2-ones and process for their preparation | |
| YU133669A (en) | Process for preparing 2-bromo-alfa-ergocryptine | |
| YU169669A (en) | Process for preparing delta-aminocyclohexadienyl alkylene-penicillin | |
| IL31950A (en) | Alkyl-6,7-aziridino-7-deoxy-alpha-thiolincosaminides and process for preparing them | |
| YU34529B (en) | Process for preparing 1,3,4-thiadiazolyl (5)-carbamides | |
| YU35584B (en) | Process for preparing 1,1,1-trichloro etane derivatives | |
| IL32243A (en) | Process for preparing quinoxaline-di-n-oxides | |
| YU33976B (en) | Process for preparing 4,20,22-bufatrienolide-rhamnoside-ethers | |
| IL27455A (en) | 3-methyl-1h-pyrazolo(3,4-b)pyridines and process for their preparation | |
| YU298769A (en) | Process for preparing omega-cyanoalkylcarbamyl-benzimidazoles | |
| YU123469A (en) | Process for preparing novel 1,3,4-thiadiazolyl-carbamates | |
| IL27443A (en) | Isoxazolo(5,4-b)pyridines and process for preparing same | |
| YU34354B (en) | Process for preparing 4-aryl-1-(4,4-diaryl-butyl)-4hydroxypiperidines | |
| YU188969A (en) | Process for preparing corticoid-21-mono-phospahtes | |
| YU40073A (en) | Process for preparing novel 11-substituted 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepine-6-ones | |
| YU34417B (en) | Process for preparing 2,4-diamino-6-alkylthio-s-triazines | |
| YU289578A (en) | Process for obtaining imidazo (4,5-b) pyridines | |
| YU1469A (en) | Process for preparing delta-carboxybenzyl-penicillin | |
| YU131369A (en) | Process for preparing 1-benzyl-3-3dimethylaminopropoxy-1h--indazole | |
| IL22912A (en) | Pyrido(3,4-b)indoles and process for their preparation | |
| YU155069A (en) | Process for preparing p-hydroxybutyrophenones | |
| CA891505A (en) | 1h-imidazo(4,5-b)pyrazin-2-ones and process for preparing | |
| YU107368A (en) | Process for preparing and isolating 1,2-dimethyl-5-nitroimidazoles |